$JAZZ
Jazz Pharmaceuticals PLC Stock $jazz

$jazz Overview Financials Valuation SEC Filings Company Website

2018 Q4 Form 10-Q Financial Statement

#000123252418000192 Filed on November 06, 2018

Income Statement

Concept	2018 Q4	2018 Q3	2017 Q3
Revenue	$476.5M	$469.4M	$411.9M
YoY Change	9.18%	13.97%	10.07%
Cost Of Revenue	$26.30M	$26.60M	$31.20M
YoY Change	4.37%	-14.74%	28.4%
Gross Profit	$441.0M	$438.6M	$376.8M
YoY Change	8.93%	16.42%	8.48%
Gross Profit Margin	92.56%	93.45%	91.48%
Selling, General & Admin	$161.9M	$155.9M	$124.5M
YoY Change	13.22%	25.18%	0.12%
% of Gross Profit	36.71%	35.54%	33.05%
Research & Development	$56.70M	$51.16M	$47.36M
YoY Change	-23.38%	8.02%	-0.91%
% of Gross Profit	12.86%	11.66%	12.57%
Depreciation & Amortization	$50.30M	$50.90M	$50.40M
YoY Change	-11.29%	0.99%	70.27%
% of Gross Profit	11.41%	11.6%	13.38%
Operating Expenses	$265.1M	$280.6M	$325.4M
YoY Change	-1.81%	-13.77%	36.76%
Operating Profit	$175.9M	$188.8M	$86.45M
YoY Change	30.44%	118.36%	-36.55%
Interest Expense	-$20.40M	-$18.92M	-$19.19M
YoY Change	-10.13%	-1.42%	3.75%
% of Operating Profit	-11.6%	-10.02%	-22.2%
Other Income/Expense, Net
YoY Change
Pretax Income	$164.6M	$169.1M	$65.04M
YoY Change	38.79%	160.0%	-44.11%
Income Tax	$5.200M	$19.30M	$1.239M
% Of Pretax Income	3.16%	11.41%	1.91%
Net Earnings	$159.5M	$149.3M	$63.53M
YoY Change	-31.32%	135.05%	-29.28%
Net Earnings / Revenue	33.47%	31.81%	15.42%
Basic Earnings Per Share	$2.69	$2.47	$1.06
Diluted Earnings Per Share	$2.64	$2.41	$1.03
COMMON SHARES
Basic Shares Outstanding	60.32M shares	60.48M shares	60.11M shares
Diluted Shares Outstanding		61.86M shares	61.44M shares

Balance Sheet

Concept	2018 Q4	2018 Q3	2017 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$824.6M	$1.064B	$452.6M
YoY Change	37.2%	135.09%	6.24%
Cash & Equivalents	$309.6M	$499.0M	$252.6M
Short-Term Investments	$515.0M	$565.0M	$200.0M
Other Short-Term Assets	$67.57M	$54.31M	$49.12M
YoY Change	-11.88%	10.57%	100.35%
Inventory	$52.96M	$43.44M	$41.34M
Prepaid Expenses	$25.02M	$23.19M	$29.25M
Receivables	$263.8M	$279.4M	$258.6M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$1.234B	$1.464B	$830.9M
YoY Change	27.44%	76.23%	11.65%
LONG-TERM ASSETS
Property, Plant & Equipment	$200.4M	$198.1M	$159.4M
YoY Change	17.8%	24.26%	59.55%
Goodwill	$927.6M	$932.4M	$941.4M
YoY Change	-2.1%	-0.96%	1.45%
Intangibles	$2.731B	$2.787B	$3.019B
YoY Change	-8.32%	-7.68%	-2.94%
Long-Term Investments
YoY Change
Other Assets	$42.70M	$56.00M	$16.42M
YoY Change	160.04%	241.07%	-56.52%
Total Long-Term Assets	$3.969B	$4.021B	$4.168B
YoY Change	-4.47%	-3.52%	-0.44%
TOTAL ASSETS
Total Short-Term Assets	$1.234B	$1.464B	$830.9M
Total Long-Term Assets	$3.969B	$4.021B	$4.168B
Total Assets	$5.203B	$5.486B	$4.999B
YoY Change	1.56%	9.74%	1.39%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$40.60M	$37.37M	$29.97M
YoY Change	66.62%	24.69%	70.04%
Accrued Expenses	$264.9M	$257.5M	$179.9M
YoY Change	33.26%	43.12%	4.33%
Deferred Revenue	$5.414M	$5.935M
YoY Change	-37.18%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$33.39M	$33.39M	$36.09M
YoY Change	-17.78%	-7.5%	0.0%
Total Short-Term Liabilities	$345.5M	$341.3M	$268.2M
YoY Change	17.53%	27.26%	15.17%
LONG-TERM LIABILITIES
Long-Term Debt	$1.563B	$1.561B	$1.544B
YoY Change	1.47%	1.09%	-28.11%
Other Long-Term Liabilities	$218.9M	$208.6M	$158.5M
YoY Change	23.93%	31.64%	49.38%
Total Long-Term Liabilities	$1.782B	$1.769B	$1.702B
YoY Change	3.78%	3.93%	-24.46%
TOTAL LIABILITIES
Total Short-Term Liabilities	$345.5M	$341.3M	$268.2M
Total Long-Term Liabilities	$1.782B	$1.769B	$1.702B
Total Liabilities	$2.127B	$2.111B	$1.970B
YoY Change	5.79%	7.11%	-20.75%
SHAREHOLDERS EQUITY
Retained Earnings	$841.1M	$1.128B	$728.1M
YoY Change	-8.38%	54.95%	130.85%
Common Stock	$2.114B	$2.078B	$1.900B
YoY Change	9.2%	9.39%	16.15%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$2.757B	$3.027B	$2.469B
YoY Change
Total Liabilities & Shareholders Equity	$5.203B	$5.486B	$4.999B
YoY Change	1.56%	9.74%	1.39%

Cashflow Statement

Concept	2018 Q4	2018 Q3	2017 Q3
OPERATING ACTIVITIES
Net Income	$159.5M	$149.3M	$63.53M
YoY Change	-31.32%	135.05%	-29.28%
Depreciation, Depletion And Amortization	$50.30M	$50.90M	$50.40M
YoY Change	-11.29%	0.99%	70.27%
Cash From Operating Activities	$224.3M	$215.3M	$188.9M
YoY Change	9.63%	13.98%	42.03%
INVESTING ACTIVITIES
Capital Expenditures	-$5.200M	-$3.900M	-$83.40M
YoY Change	-69.23%	-95.32%	379.31%
Acquisitions
YoY Change
Other Investing Activities	$38.90M	-$181.5M	-$120.0M
YoY Change	-359.33%	51.25%	-92.07%
Cash From Investing Activities	$33.70M	-$185.5M	-$203.4M
YoY Change	-205.64%	-8.8%	-86.71%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-446.4M	-14.00M	27.10M
YoY Change	1016.0%	-151.66%	-96.97%
NET CHANGE
Cash From Operating Activities	224.3M	215.3M	188.9M
Cash From Investing Activities	33.70M	-185.5M	-203.4M
Cash From Financing Activities	-446.4M	-14.00M	27.10M
Net Change In Cash	-188.4M	15.80M	12.60M
YoY Change	-241.97%	25.4%	-102.51%
FREE CASH FLOW
Cash From Operating Activities	$224.3M	$215.3M	$188.9M
Capital Expenditures	-$5.200M	-$3.900M	-$83.40M
Free Cash Flow	$229.5M	$219.2M	$272.3M
YoY Change	3.61%	-19.5%	81.05%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	1825000	USD
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Trading Symbol TradingSymbol	JAZZ
	us-gaap	Cash Flow Hedge Gain Loss To Be Reclassified Within Twelve Months CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths	1900000	USD
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	6494000	USD
CY2018Q3	jazz	Accrued Inventory Related Liabilities AccruedInventoryRelatedLiabilities	3290000	USD
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2018
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	Jazz Pharmaceuticals plc
	dei	Document Period End Date DocumentPeriodEndDate	2018-09-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0001232524
CY2018Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	60321590	shares
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2017Q4	jazz	Accrued Clinical Trial Liability AccruedClinicalTrialLiability	2181000	USD
CY2018Q3	jazz	Accrued Clinical Trial Liability AccruedClinicalTrialLiability	8387000	USD
CY2017Q4	jazz	Accrued Interest AccruedInterest	7297000	USD
CY2018Q3	jazz	Accrued Interest AccruedInterest	2678000	USD
CY2017Q4	jazz	Accrued Inventory Related Liabilities AccruedInventoryRelatedLiabilities	3002000	USD
CY2017Q4	jazz	Accrued Rebates And Other Sales Deductions AccruedRebatesAndOtherSalesDeductions	81368000	USD
CY2018Q3	jazz	Accrued Rebates And Other Sales Deductions AccruedRebatesAndOtherSalesDeductions	88443000	USD
CY2017Q4	jazz	Capital Redemption Reserve CapitalRedemptionReserve	472000	USD
CY2018Q3	jazz	Capital Redemption Reserve CapitalRedemptionReserve	472000	USD
	jazz	Contract With Customer Liability Cumulative Effect Of New Accounting Principle ContractWithCustomerLiabilityCumulativeEffectOfNewAccountingPrinciple	2240000	USD
CY2017Q3	jazz	Cost Of Product Sales Excluding Amortization Of Acquired Developed Technology And Intangible Asset Impairment CostOfProductSalesExcludingAmortizationOfAcquiredDevelopedTechnologyAndIntangibleAssetImpairment	31203000	USD
	jazz	Cost Of Product Sales Excluding Amortization Of Acquired Developed Technology And Intangible Asset Impairment CostOfProductSalesExcludingAmortizationOfAcquiredDevelopedTechnologyAndIntangibleAssetImpairment	84940000	USD
CY2018Q3	jazz	Cost Of Product Sales Excluding Amortization Of Acquired Developed Technology And Intangible Asset Impairment CostOfProductSalesExcludingAmortizationOfAcquiredDevelopedTechnologyAndIntangibleAssetImpairment	26574000	USD
	jazz	Cost Of Product Sales Excluding Amortization Of Acquired Developed Technology And Intangible Asset Impairment CostOfProductSalesExcludingAmortizationOfAcquiredDevelopedTechnologyAndIntangibleAssetImpairment	95207000	USD
CY2017Q3	jazz	Gain Losson Extinguishmentand Modificationof Debt GainLossonExtinguishmentandModificationofDebt	0	USD
	jazz	Gain Losson Extinguishmentand Modificationof Debt GainLossonExtinguishmentandModificationofDebt	0	USD
CY2018Q3	jazz	Gain Losson Extinguishmentand Modificationof Debt GainLossonExtinguishmentandModificationofDebt	0	USD
	jazz	Gain Losson Extinguishmentand Modificationof Debt GainLossonExtinguishmentandModificationofDebt	-1425000	USD
CY2017Q4	jazz	Nonvoting Euro Deferred Shares NonvotingEuroDeferredShares	55000	USD
CY2018Q3	jazz	Nonvoting Euro Deferred Shares NonvotingEuroDeferredShares	55000	USD
	jazz	Payments For Proceeds From Tenant Allowance Financing Activities PaymentsForProceedsFromTenantAllowanceFinancingActivities	0	USD
	jazz	Payments For Proceeds From Tenant Allowance Financing Activities PaymentsForProceedsFromTenantAllowanceFinancingActivities	-1253000	USD
	jazz	Paymentsto Acquire In Process Researchand Development Other Than Through Business Combination PaymentstoAcquireInProcessResearchandDevelopmentOtherThanThroughBusinessCombination	77000000	USD
	jazz	Paymentsto Acquire In Process Researchand Development Other Than Through Business Combination PaymentstoAcquireInProcessResearchandDevelopmentOtherThanThroughBusinessCombination	0	USD
	jazz	Provision For Losses On Accounts Receivable And Inventory ProvisionForLossesOnAccountsReceivableAndInventory	1825000	USD
	jazz	Provision For Losses On Accounts Receivable And Inventory ProvisionForLossesOnAccountsReceivableAndInventory	4734000	USD
CY2017Q4	jazz	Sales Return Reserve SalesReturnReserve	3651000	USD
CY2018Q3	jazz	Sales Return Reserve SalesReturnReserve	2473000	USD
	jazz	Stock Issued During Period Employee Plansand Warrants Exercises StockIssuedDuringPeriodEmployeePlansandWarrantsExercises	22793000	USD
	jazz	Stock Issued During Period Employee Plansand Warrants Exercises StockIssuedDuringPeriodEmployeePlansandWarrantsExercises	84056000	USD
CY2018Q3	jazz	Tax Cuts And Jobs Act Of2017 Measurement Period Adjustment Income Tax Expense Benefit TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit	2900000	USD
	jazz	Tax Cuts And Jobs Act Of2017 Measurement Period Adjustment Income Tax Expense Benefit TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit	2900000	USD
CY2017Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	24368000	USD
CY2018Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	37373000	USD
CY2017Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	224129000	USD
CY2018Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	279437000	USD
CY2017Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	54930000	USD
CY2018Q3	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	49845000	USD
CY2017Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	198779000	USD
CY2018Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	257453000	USD
CY2017Q4	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	3189000	USD
CY2018Q3	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	5837000	USD
CY2017Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	3213000	USD
CY2018Q3	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	2368000	USD
CY2017Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	8058000	USD
CY2018Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	46491000	USD
CY2017Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-140878000	USD
CY2018Q3	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	3293000	USD
CY2017Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	41203000	USD
CY2018Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-179466000	USD
CY2018Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-140825000	USD
CY2017Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1935486000	USD
CY2018Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	2078032000	USD
	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	17909000	USD
	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	17192000	USD
	us-gaap	Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt	149767000	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	79745000	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	75682000	USD
CY2017Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	27126000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	79579000	USD
CY2018Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	25103000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	75718000	USD
CY2017Q3	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	20772000	USD
	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	55763000	USD
CY2018Q3	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	21551000	USD
	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	63652000	USD
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	19234000	USD
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	32669000	USD
CY2017Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	47313000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	99164000	USD
CY2018Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	46989000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	154955000	USD
CY2017Q3	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
CY2018Q3	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	42896000	USD
CY2017Q4	us-gaap	Assets Assets	5123672000	USD
CY2018Q3	us-gaap	Assets Assets	5485788000	USD
CY2017Q4	us-gaap	Assets Current AssetsCurrent	968277000	USD
CY2018Q3	us-gaap	Assets Current AssetsCurrent	1464389000	USD
CY2017Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	0	USD
CY2018Q3	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	0	USD
CY2017Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	0	USD
CY2018Q3	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	0	USD
CY2017Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	601035000	USD
CY2018Q3	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	1064018000	USD
CY2017Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	601035000	USD
CY2018Q3	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	1064018000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	365963000	USD
CY2017Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	252615000	USD
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	386035000	USD
CY2018Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	499018000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-113348000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	112983000	USD
CY2017Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2018Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2017Q4	us-gaap	Common Stock Value CommonStockValue	6000	USD
CY2018Q3	us-gaap	Common Stock Value CommonStockValue	6000	USD
CY2017Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	114788000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	413987000	USD
CY2018Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	138078000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	248987000	USD
CY2017Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	24733000	USD
CY2018Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	16869000	USD
CY2017Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	8618000	USD
CY2018Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	5935000	USD
CY2018Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	7498000	USD
CY2017Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	16115000	USD
CY2018Q3	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	10934000	USD
CY2018Q1	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	14995000	USD
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	5624000	USD
CY2017Q4	us-gaap	Cumulative Effect Of New Accounting Principle In Period Of Adoption CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption	-298000	USD
CY2018Q3	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1809388000	USD
CY2017Q4	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	7673000	USD
CY2018Q3	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	10058000	USD
CY2017Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	34559000	USD
CY2018Q3	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	37582000	USD
CY2018Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	35154000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-53359000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-44658000	USD
CY2017Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	383472000	USD
CY2018Q3	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	337021000	USD
CY2018Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	386605000	USD
	us-gaap	Depreciation Depreciation	9288000	USD
	us-gaap	Depreciation Depreciation	11363000	USD
CY2017Q4	us-gaap	Derivative Asset Fair Value Gross Asset Including Not Subject To Master Netting Arrangement DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement	17633000	USD
CY2018Q3	us-gaap	Derivative Asset Fair Value Gross Asset Including Not Subject To Master Netting Arrangement DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement	8085000	USD
CY2017Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	5409000	USD
CY2018Q3	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	1258000	USD
CY2017Q4	us-gaap	Derivative Liability Fair Value Gross Liability Including Not Subject To Master Netting Arrangement DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement	5409000	USD
CY2018Q3	us-gaap	Derivative Liability Fair Value Gross Liability Including Not Subject To Master Netting Arrangement DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement	1258000	USD
CY2017Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.06
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	4.26
CY2018Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.47
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	4.78
CY2017Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.03
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	4.17
CY2018Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.41
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	4.68
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations	-672000	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations	4323000	USD
CY2017Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.019
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.205
CY2018Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.114
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.206
CY2017Q3	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	6354000	USD
	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	23816000	USD
CY2018Q3	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	3552000	USD
	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	12066000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	578017000	USD
CY2018Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	605488000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	3408566000	USD
CY2018Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	3249201000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2830549000	USD
CY2018Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2643713000	USD
CY2017Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-2224000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-9115000	USD
CY2018Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-756000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-5181000	USD
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-360000	USD
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-652000	USD
CY2017Q4	us-gaap	Goodwill Goodwill	947537000	USD
CY2018Q3	us-gaap	Goodwill Goodwill	932422000	USD
	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-15115000	USD
CY2017Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	65038000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	322192000	USD
CY2018Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	169101000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	364006000	USD
CY2017Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-273000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-637000	USD
CY2018Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-437000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1360000	USD
CY2017Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1239000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	65914000	USD
CY2018Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	19348000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	75018000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	6130000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	10116000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	22273000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	55518000	USD
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	8495000	USD
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-13999000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-23583000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	65074000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	23163000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-5623000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	7132000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	7583000	USD
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	12931000	USD
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	7244000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	10590000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-6989000	USD
CY2017Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1328000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1330000	shares
CY2018Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1381000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1297000	shares
CY2017Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	3557144000	USD
CY2018Q3	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	3392769000	USD
CY2017Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2979127000	USD
CY2018Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2787281000	USD
CY2017Q3	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-19192000	USD
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-56330000	USD
CY2018Q3	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-18920000	USD
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-59171000	USD
CY2017Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	24011000	USD
CY2018Q3	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	16497000	USD
CY2017Q4	us-gaap	Inventory Net InventoryNet	43245000	USD
CY2018Q3	us-gaap	Inventory Net InventoryNet	43435000	USD
CY2017Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	3542000	USD
CY2018Q3	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	2482000	USD
CY2017Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	15692000	USD
CY2018Q3	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	24456000	USD
CY2017Q4	us-gaap	Investments Investments	215000000	USD
CY2018Q3	us-gaap	Investments Investments	565000000	USD
CY2017Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5123672000	USD
CY2018Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5485788000	USD
CY2017Q4	us-gaap	Liabilities Current LiabilitiesCurrent	293947000	USD
CY2018Q3	us-gaap	Liabilities Current LiabilitiesCurrent	341287000	USD
CY2017Q4	us-gaap	Long Term Debt LongTermDebt	1581038000	USD
CY2018Q3	us-gaap	Long Term Debt LongTermDebt	1593969000	USD
CY2017Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	40605000	USD
CY2018Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	33387000	USD
CY2018Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	1092494000	USD
CY2018Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	33387000	USD
CY2018Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	608387000	USD
CY2018Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	33387000	USD
CY2018Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	33387000	USD
CY2018Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	8346000	USD
CY2017Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1540433000	USD
CY2018Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1560582000	USD
CY2017Q4	us-gaap	Loss Contingency Accrual Carrying Value Current LossContingencyAccrualCarryingValueCurrent	0	USD
CY2018Q3	us-gaap	Loss Contingency Accrual Carrying Value Current LossContingencyAccrualCarryingValueCurrent	57753000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-369127000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-32674000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-237072000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-428229000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	488528000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	574558000	USD
CY2017Q3	us-gaap	Net Income Loss NetIncomeLoss	63526000	USD
	us-gaap	Net Income Loss NetIncomeLoss	255641000	USD
CY2018Q3	us-gaap	Net Income Loss NetIncomeLoss	149316000	USD
	us-gaap	Net Income Loss NetIncomeLoss	287628000	USD
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	Segment
	us-gaap	Oci Before Reclassifications Net Of Tax Attributable To Parent OciBeforeReclassificationsNetOfTaxAttributableToParent	-38660000	USD
CY2017Q3	us-gaap	Operating Expenses OperatingExpenses	325401000	USD
	us-gaap	Operating Expenses OperatingExpenses	794657000	USD
CY2018Q3	us-gaap	Operating Expenses OperatingExpenses	280596000	USD
	us-gaap	Operating Expenses OperatingExpenses	984682000	USD
CY2017Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	86454000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	387637000	USD
CY2018Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	188777000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	429783000	USD
CY2017Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	26481000	USD
CY2018Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	31828000	USD
CY2017Q4	us-gaap	Other Assets Current OtherAssetsCurrent	76686000	USD
CY2018Q3	us-gaap	Other Assets Current OtherAssetsCurrent	54310000	USD
CY2017Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	16419000	USD
CY2018Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	56003000	USD
CY2017Q3	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	392000	USD
	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	-956000	USD
CY2018Q3	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	746000	USD
	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	5304000	USD
CY2017Q3	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax	56000	USD
	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax	-137000	USD
CY2018Q3	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax	107000	USD
	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax	758000	USD
CY2017Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	50870000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	159302000	USD
CY2018Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-11984000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-43945000	USD
CY2017Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	51262000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	158346000	USD
CY2018Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-11238000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-38641000	USD
CY2017Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	176608000	USD
CY2018Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	208647000	USD
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-14480000	USD
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-6970000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	56425000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	77015000	USD
	us-gaap	Payments Of Debt Restructuring Costs PaymentsOfDebtRestructuringCosts	0	USD
	us-gaap	Payments Of Debt Restructuring Costs PaymentsOfDebtRestructuringCosts	6406000	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	17909000	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	17192000	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	0	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	111100000	USD
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	290000000	USD
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	915000000	USD
	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	20072000	USD
	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	15221000	USD
CY2017Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	23182000	USD
CY2018Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	23189000	USD
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	559484000	USD
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	0	USD
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	22793000	USD
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	84056000	USD
	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	150000000	USD
	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	565000000	USD
	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	0	USD
	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	48092000	USD
CY2017Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	211283000	USD
CY2018Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	244544000	USD
CY2017Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	170080000	USD
CY2018Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	198053000	USD
	us-gaap	Reclassification From Aoci Current Period Net Of Tax Attributable To Parent ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent	-19000	USD
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	850000000	USD
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	0	USD
	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	27070000	USD
	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	17370000	USD
CY2017Q3	us-gaap	Research And Development Asset Acquired Other Than Through Business Combination Written Off ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff	75000000	USD
	us-gaap	Research And Development Asset Acquired Other Than Through Business Combination Written Off ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff	77000000	USD
CY2018Q3	us-gaap	Research And Development Asset Acquired Other Than Through Business Combination Written Off ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff	0	USD
	us-gaap	Research And Development Asset Acquired Other Than Through Business Combination Written Off ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff	0	USD
CY2017Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	47362000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	132447000	USD
CY2018Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	51160000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	169959000	USD
CY2017Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	917956000	USD
CY2018Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	1128218000	USD
CY2018Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	917605000	USD
CY2017Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	411855000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1182294000	USD
CY2018Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	469373000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1414465000	USD
CY2017Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	124523000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	401106000	USD
CY2018Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	155873000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	521665000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	79579000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	75718000	USD
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	56425000	USD
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	77015000	USD
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	1877339000	USD
CY2017Q3	us-gaap	Stockholders Equity StockholdersEquity	2469297000	USD
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	2713097000	USD
CY2018Q3	us-gaap	Stockholders Equity StockholdersEquity	3027317000	USD
CY2017Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	21577000	USD
CY2018Q3	us-gaap	Taxes Payable Current TaxesPayableCurrent	7139000	USD
CY2018Q3	us-gaap	Unrecorded Unconditional Purchase Obligation Balance On First Anniversary UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary	54700000	USD
CY2017Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	61436000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	61360000	shares
CY2018Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	61857000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	61493000	shares
CY2017Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	60108000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	60030000	shares
CY2018Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	60476000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	60196000	shares
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Concentrations of Risk</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Financial instruments that potentially subject us to concentrations of credit risk consist of cash, cash equivalents, investments and derivative contracts. Our investment policy permits investments in U.S. federal government and federal agency securities, corporate bonds or commercial paper issued by U.S. corporations, money market instruments, certain qualifying money market mutual funds, certain repurchase agreements, and tax-exempt obligations of U.S. states, agencies and municipalities and places restrictions on credit ratings, maturities, and concentration by type and issuer. We are exposed to credit risk in the event of a default by the financial institutions holding our cash, cash equivalents and investments to the extent recorded on the balance sheet.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We manage our foreign currency transaction risk and interest rate risk within specified guidelines through the use of derivatives. All of our derivative instruments are utilized for risk management purposes, and we do not use derivatives for speculative trading purposes. As of </font><font style="font-family:inherit;font-size:10pt;">September 30, 2018</font><font style="font-family:inherit;font-size:10pt;">, we had foreign exchange forward contracts with notional amounts totaling </font><font style="font-family:inherit;font-size:10pt;">$210.1 million</font><font style="font-family:inherit;font-size:10pt;">. As of </font><font style="font-family:inherit;font-size:10pt;">September 30, 2018</font><font style="font-family:inherit;font-size:10pt;">, the net liability fair value of outstanding foreign exchange forward contracts was </font><font style="font-family:inherit;font-size:10pt;">$1.0 million</font><font style="font-family:inherit;font-size:10pt;">. As of </font><font style="font-family:inherit;font-size:10pt;">September 30, 2018</font><font style="font-family:inherit;font-size:10pt;">, we had interest rate swap contracts with notional amounts totaling </font><font style="font-family:inherit;font-size:10pt;">$300.0 million</font><font style="font-family:inherit;font-size:10pt;">. These outstanding interest rate swap contracts had a fair value of </font><font style="font-family:inherit;font-size:10pt;">$7.8 million</font><font style="font-family:inherit;font-size:10pt;"> as of </font><font style="font-family:inherit;font-size:10pt;">September 30, 2018</font><font style="font-family:inherit;font-size:10pt;">. The counterparties to these contracts are large multinational commercial banks, and we believe the risk of nonperformance is not significant.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We are also subject to credit risk from our accounts receivable related to our product sales. We monitor our exposure within accounts receivable and record a reserve against uncollectible accounts receivable as necessary. We extend credit to pharmaceutical wholesale distributors and specialty pharmaceutical distribution companies, primarily in the U.S., and to other international distributors and hospitals. Customer creditworthiness is monitored and collateral is not required. We monitor deteriorating economic conditions in certain European countries which may result in variability of the timing of cash receipts and an increase in the average length of time that it takes to collect accounts receivable outstanding.</font></div></div>
	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosures in the condensed consolidated financial statements and accompanying notes. Management bases its estimates on historical experience and on assumptions believed to be reasonable under the circumstances. Actual results could differ materially from those estimates.</font></div></div>

Files In Submission

Name	View Source	Status
0001232524-18-000192-index-headers.html	Edgar Link	pending
0001232524-18-000192-index.html	Edgar Link	pending
0001232524-18-000192.txt	Edgar Link	pending
0001232524-18-000192-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
jazz-20180930.xml	Edgar Link	completed
jazz-20180930.xsd	Edgar Link	pending
jazz-20180930_cal.xml	Edgar Link	unprocessable
jazz-20180930_def.xml	Edgar Link	unprocessable
jazz-20180930_lab.xml	Edgar Link	unprocessable
jazz-20180930_pre.xml	Edgar Link	unprocessable
jazz2018q3doc.htm	Edgar Link	pending
jazzq32018ex101.htm	Edgar Link	pending
jazzq32018ex102.htm	Edgar Link	pending
jazzq32018ex103.htm	Edgar Link	pending
jazzq32018ex311.htm	Edgar Link	pending
jazzq32018ex312.htm	Edgar Link	pending
jazzq32018ex321.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$JAZZ
Jazz Pharmaceuticals PLC Stock $jazz

2018 Q4 Form 10-Q Financial Statement

#000123252418000192 Filed on November 06, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$JAZZ Jazz Pharmaceuticals PLC Stock $jazz

2018 Q4 Form 10-Q Financial Statement

#000123252418000192 Filed on November 06, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$JAZZ
Jazz Pharmaceuticals PLC Stock $jazz